发明名称 |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CATATONIA |
摘要 |
Compositions and methods for treating psychotic and neurological disorders in a subject are disclosed. The compositions and methods utilize a pharmaceutical compound that reverses or negates the effects of an NMDA receptor antagonist. The compositions and methods are effective in reducing at least catatonic features in the subject. |
申请公布号 |
US2015258097(A1) |
申请公布日期 |
2015.09.17 |
申请号 |
US201514721296 |
申请日期 |
2015.05.26 |
申请人 |
Conour James |
发明人 |
Conour James |
分类号 |
A61K31/53;A61K31/5415;A61K31/554;A61K31/519;A61K31/5513;A61K31/496;A61K31/551 |
主分类号 |
A61K31/53 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating a psychotic or neurological disorder comprising catatonic features in a subject in need thereof, comprising:
identifying a subject with a psychotic or neurological disorder comprising catatonic features; and administering to the subject a therapeutically effective amount of a pharmaceutical composition that reduces or negates the effects of an NMDA receptor antagonist and reduces the severity of the catatonic features. |
地址 |
Portland OR US |